StockSelector.com
  Research, Select, & Monitor Monday, August 19, 2019 8:06:25 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Akebia Therapeutics$4.70$.409.30%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Akebia Therapeutics has an overall rank of 3192 out of 7126 stocks based on 8 positive rankings and 8 negative rankings.

Positive Rankings
Target Prices
The average analysts' target price is $17.00 for Akebia Therapeutics using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Akebia Therapeutics is ranked 27.
Low Put/Call
Akebia Therapeutics has a low Put/Call ratio of 0.01 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Akebia Therapeutics is ranked 39.
10 Day Gain
Akebia Therapeutics rank is 130
Up Ratings Revision
During the past month, the average analyst's rating or recommendation has increased. Among companies that have been upgraded within the past month, Akebia Therapeutics is ranked 532.
PEGValue
Akebia Therapeutics has a PEG Value of $5.41. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 15.10% in the next year. Among companies with a PEG Value above the current stock price, Akebia Therapeutics is ranked 538.
Price-to-Book
Akebia Therapeutics rank is 1022
Up EPS Surprise
Akebia Therapeutics beat the consensus earnings estimate when it last reported quarterly earnings.
Debt-to-Equity
Akebia Therapeutics rank is 1227
Negative Rankings
Overbought Stochastics
Akebia Therapeutics rank is 4
Negative Net Margin
Akebia Therapeutics rank is 545
90 Day Loss
Akebia Therapeutics rank is 651
Negative Cash Growth
Akebia Therapeutics rank is 891
Negative ROE
Akebia Therapeutics rank is 937
Negative ROA
Akebia Therapeutics rank is 1057
High vPut/Call
Akebia Therapeutics has a high Put/Call ratio of 0.62 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Akebia Therapeutics is ranked 1744.
Price-to-Sales
Akebia Therapeutics rank is 2380







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.